Company Directory / Pharmaceuticals

s

PrivateFor profitPharmaceuticalsBridgewater, New Jersey, United States

sanofi-aventis U.S

The Sanofi-Aventis Group conducts manufacturing operations in the U.S. in Kansas Cit

Founded
2004
22 years ago
Staff
10001+
band, as listed
Followers
-
on LinkedIn
Funding
$3.2B
as listed, USD

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

10001+ people: larger than 100% of companies with a size listed

Age

200419002026

22 years old.

Reach

Website ranked #415,824 in the world for traffic, about 86k visits a month.

What it does

Health Care

What it is known for

pharmaceutical manufacturingservicesclinical trialsbiopharmaceuticalsrare disease treatmentmedical innovationvaccinespharmaceuticalsnewborn screening advocacyaccess to medicinesglobal healthinnovationpatient advocacydisease treatmentmedicinesdrug manufacturing

What its website runs on

Microsoft Email ProvidersMicrosoft Exchange OnlineOutlookMicrosoft ExchangeMicrosoft 365Microsoft 365 Apps & ServicesAmazon AWSBarracuda MSPSalesforceSalesforce Sales CloudBarracuda Email Security ServiceExclaimerMimecastDocuSignBarracuda NetworksGoogle Search ConsoleAWS CloudAmazon CloudFront

Funding, as listed

$3.2B raised in total

  • LatestDebt Financing, Mar 2023
  • Latest amountUSD 2,900,000,000

What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.

Annual revenue$13M
Part ofSanofi
NAICS325412, 325414, 541714

Every detail we hold

Everything the source datasets list about sanofi-aventis U.S, field by field. Contact details are held but never shown.

The company

Name
sanofi-aventis U.S
Type
For profit
Status
Private
Founded
2004
Industry
Pharmaceuticals
Categories
Health Care

Where

City
Bridgewater
Region
New Jersey
Country
United States
Markets
East Coast, Northeastern US

Size and reach

Staff band
10001+
Web traffic rank
#415,824
Monthly web visits
85,926
Annual revenue
$13M

Funding, as listed

Total
$3,182,300,000 USD
Latest round
Debt Financing
Latest round date
Mar 2023
Latest amount
2,900,000,000 USD
Listing status
private

Corporate family

Part of
Sanofi
Parent website
sanofi.com
Sub-organisations
2

Classification

NAICS
325412, 325414, 541714
SIC
2834, 2836, 8731
Keywords
16 listed, shown above
Technologies
18 detected, shown above

About this record

Sources
Crunchbase, Apollo
Last imported
Sept 2026

Growth, as the source summarises it

sanofi-aventis U.S may be growing based on the evidence of solid sales and business EPS growth, as well as successful product launches and advancements in their immunology pipeline. The company has demonstrated a record number of potential product launches, which is indicative of a robust pipeline and potential for market expansion. Additionally, the company has entered the next chapter of its 'Play to Win' strategy, which suggests a proactive approach to business growth and market competitiveness.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

Pharmaceuticals in United States.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.